Avantax Planning Partners, Inc. Bristol Myers Squibb CO Transaction History
Avantax Planning Partners, Inc.
- $2.78 Billion
- Q3 2024
A detailed history of Avantax Planning Partners, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 61,656 shares of BMY stock, worth $3.44 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
61,656
Previous 9,498
549.15%
Holding current value
$3.44 Million
Previous $394,000
709.64%
% of portfolio
0.11%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.19 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.35 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.41 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...